Lista de obras - Agnieszka Wierzbowska - Dominio Público Uruguay

A multicenter, open, non-comparative, phase II study of the combination of cladribine (2-chlorodeoxyadenosine), cytarabine, and G-CSF as induction therapy in refractory acute myeloid leukemia - a report of the Polish Adult Leukemia Group (PALG).

artículo científico publicado en 2003

A multicenter, open, noncomparative, phase II study of the combination of cladribine (2-chlorodeoxyadenosine), cytarabine, granulocyte colony-stimulating factor and mitoxantrone as induction therapy in refractory acute myeloid leukemia: a report of

scientific article published on 27 April 2005

Addition of cladribine to daunorubicin and cytarabine increases complete remission rate after a single course of induction treatment in acute myeloid leukemia. Multicenter, phase III study

artículo científico publicado en 2004

Addition of cladribine to the standard induction treatment improves outcomes in a subset of elderly acute myeloid leukemia patients. Results of a randomized Polish Adult Leukemia Group (PALG) phase II trial.

artículo científico publicado en 2017

Age-dependent determinants of infectious complications profile in children and adults after hematopoietic cell transplantation: lesson from the nationwide study.

artículo científico publicado en 2019

Angiopoietins in haematopoietic stem cell mobilisation in patients with haematological malignancies

artículo científico publicado en 2014

Assessing the efficacy of allogeneic hematopoietic stem cells transplantation (allo-HSCT) by analyzing survival end points in defined groups of acute myeloid leukemia patients: a retrospective, multicenter Polish Adult Leukemia Group study

artículo científico publicado en 2015

Associations of Ficolins With Hematological Malignancies in Patients Receiving High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantations

artículo científico publicado en 2019

Associations of ficolins and mannose-binding lectin with acute myeloid leukaemia in adults

artículo científico publicado en 2020

Azacitidine improves clinical outcomes in older patients with acute myeloid leukaemia with myelodysplasia-related changes compared with conventional care regimens

artículo científico publicado en 2017

Circulating VEGF and its soluble receptors sVEGFR-1 and sVEGFR-2 in patients with acute leukemia

artículo científico publicado en 2003

Circulating angiogenic cytokines in multiple myeloma and related disorders.

artículo científico publicado en 2003

Circulating endothelial cell kinetics and their potential predictive value during mobilization procedure.

artículo científico publicado en 2013

Circulating endothelial cells in essential thrombocythemia and polycythemia vera: correlation with JAK2-V617F mutational status, angiogenic factors and coagulation activation markers.

artículo científico publicado en 2010

Circulating endothelial cells in patients with acute myeloid leukemia

artículo científico publicado en 2005

Circulating proangiogenic molecules PIGF, SDF-1 and sVCAM-1 in patients with systemic lupus erythematosus

artículo científico publicado en 2007

Circulating total and active metalloproteinase-9 and tissue inhibitor of metalloproteinases-1 in patients with systemic lupus erythomatosus

artículo científico publicado en 2006

Cladribine added to daunorubicin-cytarabine induction prolongs survival of FLT3-ITD+ normal karyotype AML patients

artículo científico publicado en 2015

Cladribine combined with cyclophosphamide and mitoxantrone is an active salvage therapy in advanced non-Hodgkin's lymphoma.

artículo científico publicado en 2007

Cladribine combined with high doses of arabinoside cytosine, mitoxantrone, and G-CSF (CLAG-M) is a highly effective salvage regimen in patients with refractory and relapsed acute myeloid leukemia of the poor risk: a final report of the Polish Adult

artículo científico publicado en 2007

Cladribine in the treatment of acute myeloid leukemia

artículo científico publicado en 2014

Cladribine, but not fludarabine, added to daunorubicin and cytarabine during induction prolongs survival of patients with acute myeloid leukemia: a multicenter, randomized phase III study.

artículo científico publicado en 2012

Comparison of prediction models for two different peripheral stem cell collection protocols in autologous patients. How to avoid errors in calculating total blood volume to process?

artículo científico publicado en 2021

Concomitance of monosomal karyotype with at least 5 chromosomal abnormalities is associated with dismal treatment outcome of AML patients with complex karyotype - retrospective analysis of Polish Adult Leukemia Group (PALG).

artículo científico publicado en 2016

Correlation of Smac/DIABLO protein expression with the clinico-pathological features of breast cancer patients

artículo científico publicado en 2011

Current and emerging therapies for acute myeloid leukemia

scientific article published on January 2009

Decitabine improves outcomes in older patients with acute myeloid leukemia and higher blast counts

artículo científico publicado en 2015

Decitabine improves response rate and prolongs progression-free survival in older patients with newly diagnosed acute myeloid leukemia and with monosomal karyotype: A subgroup analysis of the DACO-016 trial

artículo científico publicado en 2018

Different prognosis of acute myeloid leukemia harboring monosomal karyotype with total or partial monosomies determined by FISH: retrospective PALG study.

artículo científico publicado en 2012

Donor age and C1orf132/MIR29B2C determine age-related methylation signature of blood after allogeneic hematopoietic stem cell transplantation.

artículo científico publicado en 2016

Early induction intensification with cladribine, cytarabine, and mitoxantrone (CLAM) in AML patients treated with the DAC induction regimen: a prospective, non-randomized, phase II study of the Polish Adult Leukemia Group (PALG)

scientific article published on 29 October 2019

Erratum to: Donor age and C1orf132/MIR29B2C determine age-related methylation signature of blood after allogeneic hematopoietic stem cell transplantation.

artículo científico publicado en 2016

Evaluation of circulating endothelial cells as noninvasive marker of angiogenesis in patients with chronic lymphocytic leukemia

artículo científico publicado en 2009

Expression of IAP family proteins and its clinical importance in breast cancer patients.

artículo científico publicado en 2015

Increased efficacy of intermediate-dose cytarabine + G-CSF compared to DHAP + G-CSF for stem cell mobilization in patients with lymphoma: an analysis by the polish lymphoma research group

artículo científico publicado en 2015

Infectious Complications in Patients With Multiple Myeloma After High-Dose Chemotherapy Followed by Autologous Stem Cell Transplant: Nationwide Study of the Infectious Complications Study Group of the Polish Adult Leukemia Group

artículo científico publicado en 2020

Influence of high expression of Smac/DIABLO protein on the clinical outcome in acute myeloid leukemia patients

artículo científico publicado en 2010

International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with >30% blasts

artículo científico publicado en 2015

Jagged-1: a new promising factor associated with favorable prognosis in patients with acute myeloid leukemia.

artículo científico publicado en 2014

Kinetics and apoptotic profile of circulating endothelial cells as prognostic factors for induction treatment failure in newly diagnosed acute myeloid leukemia patients

scientific article published on 11 September 2007

MiRNA-15a, miRNA-16, miRNA-126, miRNA-146a, miRNA-223 expression in autologous hematopoietic stem cell transplantation and their impact on engraftment

artículo científico publicado en 2018

Multicenter, randomized, open-label, phase III trial of decitabine versus patient choice, with physician advice, of either supportive care or low-dose cytarabine for the treatment of older patients with newly diagnosed acute myeloid leukemia

artículo científico publicado en 2012

Multivariate and subgroup analyses of a randomized, multinational, phase 3 trial of decitabine vs treatment choice of supportive care or cytarabine in older patients with newly diagnosed acute myeloid leukemia and poor- or intermediate-risk cytogene

artículo científico publicado en 2014

Outcome of a Real-Life Population of Patients With Acute Promyelocytic Leukemia Treated According to the PETHEMA Guidelines: The Polish Adult Leukemia Group (PALG) Experience

artículo científico publicado en 2019

Plasma levels of angiogenic factors and circulating endothelial cells in essential thrombocythemia: correlation with cytoreductive therapy and JAK2-V617F mutational status

artículo científico publicado en 2010

Polymorphism of CD44 influences the efficacy of CD34(+) cells mobilization in patients with hematological malignancies

artículo científico publicado en 2014

Post hoc analysis of the relationship between baseline white blood cell count and survival outcome in a randomized Phase III trial of decitabine in older patients with newly diagnosed acute myeloid leukemia

artículo científico publicado en 2015

Prognostic value of inhibitor of apoptosis protein family expression in patients with acute myeloid leukemia.

artículo científico publicado en 2014

Protective environment in hematopoietic cell transplantation centers: results of a survey of the Polish Federation of Bone Marrow Transplant Centers

artículo científico publicado en 2021

Recent clinical trials of cladribine in hematological malignancies and autoimmune disorders

artículo científico publicado en 2006

Relationship between baseline white blood cell count and renal and hepatic function in older patients with acute myeloid leukemia

artículo científico publicado en 2013

Safety and efficacy of talacotuzumab plus decitabine or decitabine alone in patients with acute myeloid leukemia not eligible for chemotherapy: results from a multicenter, randomized, phase 2/3 study

artículo científico publicado en 2020

Safety and feasibility of therapeutic platelet depletion with Spectra Optia in a pregnant woman.

artículo científico publicado en 2017

Significance of Bax expression in breast cancer patients

scientific article published on 01 October 2011

The Expression of the SLIT-ROBO Family in Adult Patients with Acute Myeloid Leukemia

scientific article published on 28 February 2019

The Role of Complement Activating Collectins and Associated Serine Proteases in Patients With Hematological Malignancies, Receiving High-Dose Chemotherapy, and Autologous Hematopoietic Stem Cell Transplantations (Auto-HSCT)

The early reduction of leukemic blasts in bone marrow on day 6 of induction treatment is predictive for complete remission rate and survival in adult acute myeloid leukemia; the results of multicenter, prospective Polish Adult Leukemia Group study

artículo científico publicado en 2011

The effects of intracoronary autologous mononuclear bone marrow cell transplantation on cardiac arrhythmia and heart rate variability

artículo científico publicado en 2009

The efficacy of sapacitabine in treating patients with acute myeloid leukemia

artículo científico publicado en 2018

The kinetics and apoptotic profile of circulating endothelial cells in autologous hematopoietic stem cell transplantation in patients with lymphoproliferative disorders

artículo científico publicado en 2013

The kinetics of hematopoietic niche cytokines and their influence on mobilization efficacy and timing in patients with hematological malignancies.

artículo científico publicado en 2014

The role of NF-κB and Smac/DIABLO proteins in the treatment response and survival of acute myeloid leukemia patients

The role of neuronal apoptosis inhibitory protein (NAIP) in acute myeloid leukemia patients

Treatment of elderly patients with acute myeloid leukemia adjusted for performance status and presence of comorbidities: a Polish Adult Leukemia Group study

scientific article published on 21 January 2015

VEGF, ANGPT1, ANGPT2, and MMP-9 expression in the autologous hematopoietic stem cell transplantation and its impact on the time to engraftment.

artículo científico publicado en 2017

Wyniki leczenia chorych na zespoły mielodysplastyczne z zastosowaniem transplantacji allogenicznych komórek krwiotwórczych: badanie wieloośrodkowe Polskiej Grupy ds. Leczenia Białaczek PALG

artículo científico publicado en 2015

Lista de obras de Agnieszka Wierzbowska

A multicenter, open, non-comparative, phase II study of the combination of cladribine (2-chlorodeoxyadenosine), cytarabine, and G-CSF as induction therapy in refractory acute myeloid leukemia - a report of the Polish Adult Leukemia Group (PALG).

A multicenter, open, noncomparative, phase II study of the combination of cladribine (2-chlorodeoxyadenosine), cytarabine, granulocyte colony-stimulating factor and mitoxantrone as induction therapy in refractory acute myeloid leukemia: a report of

Addition of cladribine to daunorubicin and cytarabine increases complete remission rate after a single course of induction treatment in acute myeloid leukemia. Multicenter, phase III study

Addition of cladribine to the standard induction treatment improves outcomes in a subset of elderly acute myeloid leukemia patients. Results of a randomized Polish Adult Leukemia Group (PALG) phase II trial.

Age-dependent determinants of infectious complications profile in children and adults after hematopoietic cell transplantation: lesson from the nationwide study.

Angiopoietins in haematopoietic stem cell mobilisation in patients with haematological malignancies

Assessing the efficacy of allogeneic hematopoietic stem cells transplantation (allo-HSCT) by analyzing survival end points in defined groups of acute myeloid leukemia patients: a retrospective, multicenter Polish Adult Leukemia Group study

Associations of Ficolins With Hematological Malignancies in Patients Receiving High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantations

Associations of ficolins and mannose-binding lectin with acute myeloid leukaemia in adults

Azacitidine improves clinical outcomes in older patients with acute myeloid leukaemia with myelodysplasia-related changes compared with conventional care regimens

Circulating VEGF and its soluble receptors sVEGFR-1 and sVEGFR-2 in patients with acute leukemia

Circulating angiogenic cytokines in multiple myeloma and related disorders.

Circulating endothelial cell kinetics and their potential predictive value during mobilization procedure.

Circulating endothelial cells in essential thrombocythemia and polycythemia vera: correlation with JAK2-V617F mutational status, angiogenic factors and coagulation activation markers.

Circulating endothelial cells in patients with acute myeloid leukemia

Circulating proangiogenic molecules PIGF, SDF-1 and sVCAM-1 in patients with systemic lupus erythematosus

Circulating total and active metalloproteinase-9 and tissue inhibitor of metalloproteinases-1 in patients with systemic lupus erythomatosus

Cladribine added to daunorubicin-cytarabine induction prolongs survival of FLT3-ITD+ normal karyotype AML patients

Cladribine combined with cyclophosphamide and mitoxantrone is an active salvage therapy in advanced non-Hodgkin's lymphoma.

Cladribine combined with high doses of arabinoside cytosine, mitoxantrone, and G-CSF (CLAG-M) is a highly effective salvage regimen in patients with refractory and relapsed acute myeloid leukemia of the poor risk: a final report of the Polish Adult

Cladribine in the treatment of acute myeloid leukemia

Cladribine, but not fludarabine, added to daunorubicin and cytarabine during induction prolongs survival of patients with acute myeloid leukemia: a multicenter, randomized phase III study.

Comparison of prediction models for two different peripheral stem cell collection protocols in autologous patients. How to avoid errors in calculating total blood volume to process?

Concomitance of monosomal karyotype with at least 5 chromosomal abnormalities is associated with dismal treatment outcome of AML patients with complex karyotype - retrospective analysis of Polish Adult Leukemia Group (PALG).

Correlation of Smac/DIABLO protein expression with the clinico-pathological features of breast cancer patients

Current and emerging therapies for acute myeloid leukemia

Decitabine improves outcomes in older patients with acute myeloid leukemia and higher blast counts

Decitabine improves response rate and prolongs progression-free survival in older patients with newly diagnosed acute myeloid leukemia and with monosomal karyotype: A subgroup analysis of the DACO-016 trial

Different prognosis of acute myeloid leukemia harboring monosomal karyotype with total or partial monosomies determined by FISH: retrospective PALG study.

Donor age and C1orf132/MIR29B2C determine age-related methylation signature of blood after allogeneic hematopoietic stem cell transplantation.

Early induction intensification with cladribine, cytarabine, and mitoxantrone (CLAM) in AML patients treated with the DAC induction regimen: a prospective, non-randomized, phase II study of the Polish Adult Leukemia Group (PALG)

Erratum to: Donor age and C1orf132/MIR29B2C determine age-related methylation signature of blood after allogeneic hematopoietic stem cell transplantation.

Evaluation of circulating endothelial cells as noninvasive marker of angiogenesis in patients with chronic lymphocytic leukemia

Expression of IAP family proteins and its clinical importance in breast cancer patients.

Increased efficacy of intermediate-dose cytarabine + G-CSF compared to DHAP + G-CSF for stem cell mobilization in patients with lymphoma: an analysis by the polish lymphoma research group

Infectious Complications in Patients With Multiple Myeloma After High-Dose Chemotherapy Followed by Autologous Stem Cell Transplant: Nationwide Study of the Infectious Complications Study Group of the Polish Adult Leukemia Group

Influence of high expression of Smac/DIABLO protein on the clinical outcome in acute myeloid leukemia patients

International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with >30% blasts

Jagged-1: a new promising factor associated with favorable prognosis in patients with acute myeloid leukemia.

Kinetics and apoptotic profile of circulating endothelial cells as prognostic factors for induction treatment failure in newly diagnosed acute myeloid leukemia patients

MiRNA-15a, miRNA-16, miRNA-126, miRNA-146a, miRNA-223 expression in autologous hematopoietic stem cell transplantation and their impact on engraftment

Multicenter, randomized, open-label, phase III trial of decitabine versus patient choice, with physician advice, of either supportive care or low-dose cytarabine for the treatment of older patients with newly diagnosed acute myeloid leukemia

Multivariate and subgroup analyses of a randomized, multinational, phase 3 trial of decitabine vs treatment choice of supportive care or cytarabine in older patients with newly diagnosed acute myeloid leukemia and poor- or intermediate-risk cytogene

Outcome of a Real-Life Population of Patients With Acute Promyelocytic Leukemia Treated According to the PETHEMA Guidelines: The Polish Adult Leukemia Group (PALG) Experience

Plasma levels of angiogenic factors and circulating endothelial cells in essential thrombocythemia: correlation with cytoreductive therapy and JAK2-V617F mutational status

Polymorphism of CD44 influences the efficacy of CD34(+) cells mobilization in patients with hematological malignancies

Post hoc analysis of the relationship between baseline white blood cell count and survival outcome in a randomized Phase III trial of decitabine in older patients with newly diagnosed acute myeloid leukemia

Prognostic value of inhibitor of apoptosis protein family expression in patients with acute myeloid leukemia.

Protective environment in hematopoietic cell transplantation centers: results of a survey of the Polish Federation of Bone Marrow Transplant Centers

Recent clinical trials of cladribine in hematological malignancies and autoimmune disorders

Relationship between baseline white blood cell count and renal and hepatic function in older patients with acute myeloid leukemia

Safety and efficacy of talacotuzumab plus decitabine or decitabine alone in patients with acute myeloid leukemia not eligible for chemotherapy: results from a multicenter, randomized, phase 2/3 study

Safety and feasibility of therapeutic platelet depletion with Spectra Optia in a pregnant woman.

Significance of Bax expression in breast cancer patients

The Expression of the SLIT-ROBO Family in Adult Patients with Acute Myeloid Leukemia

The Role of Complement Activating Collectins and Associated Serine Proteases in Patients With Hematological Malignancies, Receiving High-Dose Chemotherapy, and Autologous Hematopoietic Stem Cell Transplantations (Auto-HSCT)

The early reduction of leukemic blasts in bone marrow on day 6 of induction treatment is predictive for complete remission rate and survival in adult acute myeloid leukemia; the results of multicenter, prospective Polish Adult Leukemia Group study

The effects of intracoronary autologous mononuclear bone marrow cell transplantation on cardiac arrhythmia and heart rate variability

The efficacy of sapacitabine in treating patients with acute myeloid leukemia

The kinetics and apoptotic profile of circulating endothelial cells in autologous hematopoietic stem cell transplantation in patients with lymphoproliferative disorders

The kinetics of hematopoietic niche cytokines and their influence on mobilization efficacy and timing in patients with hematological malignancies.

The role of NF-κB and Smac/DIABLO proteins in the treatment response and survival of acute myeloid leukemia patients

The role of neuronal apoptosis inhibitory protein (NAIP) in acute myeloid leukemia patients

Treatment of elderly patients with acute myeloid leukemia adjusted for performance status and presence of comorbidities: a Polish Adult Leukemia Group study

VEGF, ANGPT1, ANGPT2, and MMP-9 expression in the autologous hematopoietic stem cell transplantation and its impact on the time to engraftment.

Wyniki leczenia chorych na zespoły mielodysplastyczne z zastosowaniem transplantacji allogenicznych komórek krwiotwórczych: badanie wieloośrodkowe Polskiej Grupy ds. Leczenia Białaczek PALG